[Comments on the article "Biological, clinical and epidemiological aspects of latent tuberculosis" by Jorge A. Barrios Payán et al.].
Eduardo
E
Hernández-Garduño
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000995:Antitubercular Agents / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D018450:Disease Progression; D018562:Disease Transmission, Infectious / Q000517:prevention & control; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000453:epidemiology; D006801:Humans; D016867:Immunocompromised Host; D007223:Infant; D007538:Isoniazid / Q000008:administration & dosage / Q000627:therapeutic use; D055985:Latent Tuberculosis / Q000188:drug therapy / Q000453:epidemiology / Q000635:transmission; D008800:Mexico / Q000453:epidemiology; D009765:Obesity / Q000453:epidemiology; D012307:Risk Factors; D055815:Young Adult
D000995:Antitubercular Agents; D007538:Isoniazid